Attachments:
FileDescriptionFile size
Download this file (HTL to Participate in Oppenheimer Annual Conf-Final.pdf)23-February-2021-press-releaseHamilton Thorne to Participate in Oppenheimer Annual Healthcare Conference on March 17, 2021100 kB

HAMILTON THORNE TO PARTICIPATE IN OPPENHEIMER ANNUAL HEALTHCARE CONFERENCE ON MARCH 17, 2021

BEVERLY, MA and TORONTO, Ontario – February 24, 2021 – Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that management will participate in the Oppenheimer Annual Healthcare Conference on Wednesday, March 17, 2021. 

David Wolf, President and CEO of Hamilton Thorne Ltd., will represent the company at a virtual session to be held at 3:50 PM ET on March 17, 2021 and will be available for virtual one-on-one meetings during that day. To schedule a meeting with management, please contact your conference representative or email  ir [AT] hamiltonthorne [DOT] ltd.

About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Neither the TSX Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

David Wolf, President & CEO
Hamilton Thorne Ltd.
978-921-2050
ir [AT] hamiltonthorne [DOT] ltd
Michael Bruns, CFO
Hamilton Thorne Ltd.    
978-921-2050 
ir [AT] hamiltonthorne [DOT] ltd
Glen Akselrod
Bristol Investor Relations   
905-326-1888
glen [AT] bristolir [DOT] com

Subscribe to Our Investor Email List